15,412 research outputs found
(E,E)-N1,N2-Bis(2,6-difluorobenzylidene)ethane-1,2-diamine.
The asymmetric unit of the title compound, C16H12F4N2, comprises half of the potentially bidentate Schiff base ligand, with an inversion centre located at the mid-point of the central C—C bond. The crystal packing is stabilized by intermolecular C—H⋯N and π–π interactions [centroid–centroid distance = 3.6793 (12) Å and interplanar spacing = 3.4999 (7) Å]
Tau-aggregation inhibitor therapy for Alzheimer's disease
Article Accepted Date: 9 December 2013 Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.Peer reviewedPublisher PD
The study of comets, part 2
Flyby missions and systematic observations of comets are projected for studying comet nuclei and cometary dust tail structures
Rationale for tau aggregation inhibitor therapy in Alzheimer's disease and other tauopathies
Preprin
- …